Improving outcomes for hip fracture patients with heart injury through faster surgery
HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial
The HIP ATTACK-2 trial is looking to help people with hip fractures and heart issues by comparing faster surgery within six hours of getting to the hospital to regular surgery, to see if getting treated quicker can help them recover better and live a healthier life.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10673739 on NIH RePORTER |
What this research studies
The HIP ATTACK-2 trial aims to enhance the recovery of patients who suffer from hip fractures and also have acute heart injuries. This research will compare the effects of accelerated surgery, performed within six hours of hospital admission, against standard surgical care. By focusing on patients with elevated serum troponin levels, the study seeks to determine if quicker surgical intervention can reduce mortality rates, improve mobility, and enhance overall quality of life. Participants will be monitored for their ability to walk independently and for any complications arising from their treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who have sustained a hip fracture and have elevated serum troponin levels indicating acute heart injury.
Not a fit: Patients who do not have a hip fracture or those without any signs of acute heart injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the risk of death and improve recovery outcomes for hip fracture patients with heart injuries.
How similar studies have performed: Previous studies have indicated that accelerated surgical interventions can improve outcomes for similar patient populations, suggesting a promising avenue for this trial.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Slobogean, Gerard — University of Maryland Baltimore
- Study coordinator: Slobogean, Gerard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.